Articles by Martin Lush
Martin Lush is the Global Vice President of NSF Health Sciences. An organisation of global experts in consultancy, auditing, education, analytical and certification services to pharmaceutical, biotechnology, medical device and dietary supplements companies.
With over 37 years’ experience in pharmaceutical and health care industries, he has provided education, trouble shooting, consultancy, due diligence services to clients in over 50 countries. Martin is a ‘Qualified Person’ (QP) under permanent provisions and Honorary Lecturer at the School of Pharmacy. University of Strathclyde.
Over-complexity is the silent killer for many companies, and it’s a proven fact. The largest 200 companies in the Global Fortune 500 listing lose approximately 10.2% of shareholder value every year due to complexity. Read NSF's top tips for cutting through complexity!
In a world of ever-increasing and sometimes unpredictable change, it has never been more important for pharmaceutical companies to bounce back stronger from “brutal disruptions.” The trouble with the old adages, “proper planning prevents poor performance” and “fail to plan, plan to fail,” is that planning only works when you have an idea of what’s coming.
Are you curious about the L&D strategies of some of the U.K.'s top companies?
Find out what they're up to in findcourses.co.uk's second annual U.K. L&D Report!
LOOKING FOR TRAINING?
Good news! findcourses.co.uk offers a free consultancy service to help compare training for you and your team.
Is your company looking to take on an apprentice?
Download your free copy of the ultimate guide to apprenticeships for companies